Where T1D is Prioritized for the COVID Vaccine

Kaiser Family Foundation, Table 3, as of February 21, 2021

https://www.kff.org/policy-watch/the-next-phase-of-vaccine-distribution-high-risk-medical-conditions/  

Alabama

Alaska (confirmed by JDRF Feb 26, 2021)

Arkansas

Colorado (confirmed by CBS Denver March 3, 2021)

Delaware

Florida (requires doctor's authorization, confirmed by Sun Sentinel)

Georgia (confirmed by dph.georgia.gov on March 13,2021)

Illinois

Indiana (confirmed by local Fox affiliate March 11,2021)

Iowa (confirmed by Iowa DPH press release March 5,2021)

Kansas

Kentucky (confirmed by local Fox affiliate March 12,2021)

Louisiana (confirmed by state website March 12, 2021)

Maryland

Michigan

Minnesota (confirmed by Minneapolis Star Tribune March 3, 2021) 

Mississippi

Montana

Nebraska

New Hampshire

New Mexico

New York

North Carolina

Ohio

Oklahoma

Rhode Island

South Carolina (confirmed by CBS News 19, March 3, 2021)

Tennessee

Texas (confirmed by JDRF Feb 26, 2021)

Utah

Vermont (confirmed by JDRF February 22, 2021)

Virginia

Washington (does not differentiate between type 1 and 2. Confirmed doh.wa.gov March 6, 2021) 

Wisconsin

Wyoming 

New York Times Table:

https://www.nytimes.com/2021/03/09/us/covid-vaccine-eligible-preexisting-conditions.html